On October 2, 2025, Standard Chartered PLC purchased 505,871 of its own ordinary shares at a volume-weighted average price of 1,456.66 pence per share, with prices ranging from a low of 1,440.00 pence to a high of 1,479.00 pence. The purchases were made through Goldman Sachs International as part of a previously announced buy-back program. As of the trading day preceding this announcement, Standard Chartered had applied US$422,835,570.95 to share purchases under the buy-back program. Following cancellation of the purchased shares, the company will have 2,293,098,096 ordinary shares in issue, representing the total number of voting rights.
Standard Chartered PLC ("SC") announces that on 02 October 2025 it purchased the following number of its ordinary shares of US$0.50 each from Goldman Sachs International, pursuant to the share buy-back programme previously detailed in the announcement of 31 July 2025 (the "Buy-back").
Aggregated information on the ordinary shares purchased on 02 October 2025 pursuant to the Buy-back:
Date of purchase:
02 October 2025
Aggregate number of shares purchased:
505,871
Lowest price paid per share (GB Pence):
1,440.00 pence
Highest price paid per share (GB Pence):
1,479.00 pence
Volume weighted average price paid per share (GB Pence):
1,456.66 pence
Aggregated information on the ordinary shares purchased on 02 October 2025 pursuant to the Buy-back according to each trading venue:
Venue
Volume weighted average price paid per share (GB pence)
Aggregate number of shares purchased
Lowest price paid per share (GB pence)
Highest price paid per share (GB pence)
London Stock Exchange
1,456.29
354,110
1,440.00
1,479.00
CBOE BXE
1,458.28
50,587
1,440.50
1,478.50
CBOE CXE
1,457.16
101,174
1,440.00
1,478.50
As at close of business London time on the trading day preceding the date of this announcement, SC had applied an aggregate of US$422,835,570.95 to share purchases pursuant to the Buy-back.
SC intends to cancel the purchased shares. Following the cancellation of the purchased shares, SC will have 2,293,098,096 ordinary shares in issue. Therefore, the total number of voting rights in SC will be 2,293,098,096.
Any such share purchases will be effected in accordance with certain pre-set parameters and limits, and in accordance with applicable law and regulation as described in more detail in SC's announcement of 31 July 2025.
In accordance with Article 5(1)(b) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), a full breakdown of the individual trades is attached to this announcement.
Manus Costello, Head of Investor Relations: +44 (0) 20 7885 5934
Shaun Gamble, Director, Group Media Relations: +44 (0) 20 7885 5934
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.
